Showing 351-360 of 2310 results for "".
Active Vitiligo: What to Look For
https://practicaldermatology.com/series/updates-vitiligo/active-vitiligo-what-to-look-for/24156/John E. Harris, MD, founding director of the Autoimmune Therapeutics Institute at the University of Massachusetts Chan Medical School, talks with Practical Dermatology Chief Medical Editor Neal Bhatia, MD, about the clinical signs of active vitiligo.DermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dr-bhatia-and-dr-schlesinger-discuss-collaboration-oncologists/26304/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, and Editorial Board member Todd Schlesinger, MD, discuss the importance of collaborating with oncologists on advanced skin cancer cases as immunotherapy technology continues to progress.Pigmentation: Melasma vs. Postinflammatory Hyperpigmentation
https://practicaldermatology.com/conferences/maui-derm-2024/pigmentation-melasma-vs-hyperpigmentation-vitiligo-treatments-and-full-spectrum-photo-protection/20247/Chief Medical Editor Neal Bhatia, MD and Pearl Grimes, MD, discuss Dr. Grimes’ presentations on pigmentation, including the difference between melasma and postinflammatory hyperpigmentation, and the importance of photo-protection in darker skin types.Exciting Developments in Treating Pediatric Dermatology
https://practicaldermatology.com/conferences/maui-derm-2024/exciting-developments-in-treating-pediatric-dermatology/20246/Chief Medical Editor Neal Bhatia, MD and Lawrence Eichenfield, MD, discuss the range of therapies currently approved or in the pipeline for atopic dermatitis, pruritus, pediatric acne--and the importance of messaging on TikTok.“No Drug is 100 Percent.”
https://practicaldermatology.com/conferences/maui-derm-2024/no-drug-is-100-percent/20242/Jason Hawkes, MD and Chief Medical Editor Neal Bhatia, MD discuss how the current array of options for patients of chronic spontaneous urticaria (CSU) expand treatment options for hives beyond antihistamines.Approaches to AK Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/approaches-to-ak-management/20133/When confronted with AK, dermatologists are armed with various treatment options, including destructive and field-directed therapies. Vishal Patel, MD and Neal Bhatia, MD talk about their approach to decision-making.Skin Checks and Patient Education on Actinic Keratoses
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-checks-and-patient-education-on-actinic-keratoses/20132/During skin checks, it's important for dermatologists to educate patients, especially younger ones, about the extent of sun damage and the benefits of field treatments. Anthony Rossi, MD and Vishal Patel, MD discuss their approaches.Ask an Expert: What's the Role for Infliximab in HS?
https://practicaldermatology.com/topics/general-topics/ask-an-expert-whats-the-role-for-infliximab-in-hs/19671/Evidence shows that infliximab, with its weight-based dosing, can be effective for hidradenitis suppurative. Steven Cohen, MD discusses the data and practical considerations with host Adam Friedman, MD.Insights on Care for Skin of Color, Part 2
https://practicaldermatology.com/topics/skin-of-color/insights-on-care-for-skin-of-color-part-2/18185/Hilary Baldwin, MD and James Q. Del Rosso, DO continue their discussion with host Neal Bhatia, MD about managing skin of color. They address long-term management strategies and the need for cultural awareness.Insights on Care for Skin of Color, Part 1
https://practicaldermatology.com/topics/skin-of-color/insights-on-care-for-skin-of-color-part-1/18184/The full spectrum of skin phototypes means that there is no "typical presentation" of skin disease. Host Neal Bhatia, MD speaks with James Q. Del Rosso, DO and Hilary Baldwin, MD about patients' needs during isolation and beyond.